Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ: EPRX · Real-Time Price · USD
5.81
-0.49 (-7.78%)
At close: Jul 24, 2026, 4:00 PM EDT
5.80
-0.01 (-0.17%)
Pre-market: Jul 27, 2026, 8:11 AM EDT
Eupraxia Pharmaceuticals Market Cap
Eupraxia Pharmaceuticals has a market cap or net worth of $381.3 million as of July 27, 2026. Its market cap has increased by 106.59% in one year.
Market Cap
381.30M
Enterprise Value
273.53M
1-Year Change
106.59%
Ranking
Category
Stock Price
$5.81
ChartMarket Cap Chart
Since March 9, 2021, Eupraxia Pharmaceuticals's market cap has increased from $61.62M to $381.30M, an increase of 518.82%. That is a compound annual growth rate of 40.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 381.30M | 0.02% |
| Dec 31, 2025 | 381.21M | 241.41% |
| Dec 31, 2024 | 111.66M | 0.72% |
| Dec 29, 2023 | 110.86M | 90.37% |
| Dec 30, 2022 | 58.23M | 111.19% |
| Dec 31, 2021 | 27.57M | -55.25% |
| Mar 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Benitec Biopharma | 394.04M |
| Autolus Therapeutics | 385.91M |
| vTv Therapeutics | 381.34M |
| Century Therapeutics | 380.55M |
| Prelude Therapeutics | 379.85M |
| Sutro Biopharma | 379.13M |
| Atea Pharmaceuticals | 378.53M |
| C4 Therapeutics | 375.93M |